Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
national blog main
national top stories
5
×
san francisco blog main
boston top stories
cancer
national
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
democrats
fda
ipo
medical device
novartis
orbimed
republicans
vc
abbvie
actavalon
acute myeloid leukemia
What
public
5
×
ipo
company
drugs
files
firms
life
science
week
advance
america
answer
away
bio
biogen
biology
biotechs
blood
broader
cancer
club
companies
continued
continues
convoluted
crop
cytokine
democratic
democrats
dems
detect
developing
discontent
dreams
election
enhanced
exceeded
grail
group
haul
Language
unset
Current search:
public
×
" national top stories "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M